"10.1371_journal.pone.0010744","plos one","2010-05-20T00:00:00Z","Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga","Department of Pharmacology and Toxicology, University of Antioquia Medical School, Medellín, Colombia; Grupo Investigador de Problemas en Enfermedades Infecciosas, University of Antioquia Medical School, Medellín, Colombia; Section of Infectious Diseases, Department of Medicine, Hospital Universitario San Vicente de Paul and University of Antioquia Medical School, Medellín, Colombia","Conceived and designed the experiments: AFZ OV. Performed the experiments: AFZ MA JJC CAR OV. Analyzed the data: AFZ OV. Contributed reagents/materials/analysis tools: AFZ MA JJC CAR OV. Wrote the paper: AFZ CAR OV. Gave final approval of the version to be published: OV AFZ MA JJC CAR. Provided care for the animals: MA JJC CAR.","Zuluaga has received honoraries for speaking from Pfizer, Allergan and Roche, received financial support from Pfizer, AztraZeneca and Merck Sharp & Dohme (MSD) to participate in scientific international meetings, and has been a member of advisory boards for Pfizer. Rodriguez received financial support to participate in international meetings from AztraZeneca and Wyeth. Agudelo received financial support to participate in international meetings from Wyeth and Bristol-Myers Squibb (BMS), respectively. Vesga has received honoraries for lectures and financial support to participate in international meetings from GlaxoSmithKline, Pfizer, BMS, AstraZeneca, MSD, Sanofi-Aventis and Wyeth, and has been a member of advisory boards for Wyeth. None of these or any other pharmaceutical companies supported the present study.","2010","05","Andres F Zuluaga","AFZ",5,TRUE,2,5,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
